Common Stock, Shares, Outstanding of ANAPTYSBIO, INC from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ANAPTYSBIO, INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • ANAPTYSBIO, INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 28,018,845, a 8.1% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ANAPTYSBIO, INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 28,018,845 -2,454,155 -8.1% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 27,575,152 -2,853,530 -9.4% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 27,972,997 +538,964 +2% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 30,387,893 +3,071,249 +11% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 30,473,000 +3,876,000 +15% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 30,428,682 +3,853,504 +14% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 27,434,033 +903,338 +3.4% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 27,316,644 +298,447 +1.1% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 26,597,000 -1,916,000 -6.7% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 26,575,178 -1,778,989 -6.3% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 26,530,695 -1,700,649 -6% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 27,018,197 -1,159,393 -4.1% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 28,513,000 +866,000 +3.1% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 28,354,167 +900,384 +3.3% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 28,231,344 +798,735 +2.9% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 28,177,590 +810,235 +3% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 27,647,000 +291,000 +1.1% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 27,453,783 +107,555 +0.39% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 27,432,609 +145,271 +0.53% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 27,367,355 +90,240 +0.33% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 27,356,000 +101,000 +0.37% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 27,346,228 +248,186 +0.92% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 27,287,338 +242,811 +0.9% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 27,277,115 +270,822 +1% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 27,255,000 +333,000 +1.2% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 27,098,042 +349,329 +1.3% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 27,044,527 +3,016,023 +13% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 27,006,293 +3,189,336 +13% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 26,922,000 +3,131,000 +13% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 26,748,713 +6,252,425 +31% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 24,028,504 +3,738,597 +18% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 23,816,957 +3,567,662 +18% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 23,791,000 +21,140,000 +797% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 20,496,288 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 20,289,907 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 20,249,295 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 2,651,000 31 Dec 2016 10-K 05 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.